How Risperdal Manufacturers Hid Clinical Trial Data

How Risperdal Manufacturers Hid Clinical Trial Data
In the wake of the $70 million Risperdal decision from this previous July, Risperdal manufacturers Janssen Pharmaceuticals and its moms and dad company, Johnson & Johnson (J&J), are most likely scrambling to find a new technique for the countless additional pending Risperdal claims. One of the strongest pieces of evidence provided in the Risperdal trials is a video deposition of former FDA Commissioner David Kessler testifying that Janssen and J&J manipulated scientific trial data presented to…Read the whole story here

 

Johnson & Johnson Ordered To Pay$70,000,000 In Risperdal Lawsuit

A teenager from Tennessee has actually won a $70 million case versus Johnson & Johnson. He declared that the business’s Risperdal drug caused him to grow female breasts. While others have actually taken the antipsychotic medication and experienced the exact same negative effects, none have been granted this much. Those who need more Risperdal suit details can visit the websites that concentrates on cases involving this drug. The case was heard by a jury in Philadelphia and they identified that J&J did not sufficient …

See all stories on this subject


Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *